Comment: CVS Health’s vertical deal for Signify Health could raise entry barrier, market power concerns
By Flavia Fortes ( September 8, 2022, 19:29 GMT | Comment) -- CVS Health’s $8 billion bid for home care provider Signify Health could attract antitrust scrutiny over entry barriers and the companies’ strengthened position in the healthcare market. While the companies say there are no overlapping businesses between them, antitrust regulators have been wary of market consolidation in general, particularly in healthcare.CVS Health’s $8 billion bid for home care provider Signify Health could attract antitrust scrutiny over entry barriers and the companies’ strengthened position in the healthcare market....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.